Indevus Pharmaceuticals (NasdaqNM:IDEV) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indevus Pharmaceuticals (NasdaqNM:IDEV)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SemiBull who started this subject	12/18/2003 9:04:31 AM
From: tom r. phillips	Read Replies (2) of 78

fiscal 2003 results out. there's a lot to like here. strong cash position and a healthy pipeline. e.g.: "The U.S. overactive bladder market continues to grow significantly and is expected to reach sales of approximately $1.2 billion in 2003," said Dr. Cooper. "We are in late-stage negotiations for a marketing partnership which will give us the resources to position trospium favorably in this large and expanding market and thus to achieve the commercial potential of this asset. We are well along in our market introduction plans and we expect to be in a position to launch the product in a timely fashion following anticipated FDA approval in 2004." biz.yahoo.com tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next